From: Multi-tyrosine kinase inhibitors in preclinical studies for pediatric CNS AT/RT: Evidence for synergy with Topoisomerase-I inhibition
Inhibitor, IC50 (μM)
BT 12
BT 16
KCCF1
Sorafenib
3.3
2.8
3.6
Sunitinib
3.2
3.7
Irinotecan
2.0
4.1
6.7
SN-38
0.09
0.03
4.6